Distinctive Infectious Complications In Patients With Central Nervous System Lymphoma Undergoing Thiotepa, Busulfan, and Cyclophosphamide (TBC) Conditioned Autologous Stem Cell Transplantation

類似資料

• A Comprehensive Assessment of Toxicities in Patients with CNS Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan and Cyclophosphamide Conditioning
  著者:: Scordo, Michael, 等
  出版事項: (2016)
• ATG vs thiotepa with busulfan and cyclophosphamide in matched-related bone marrow transplantation for thalassemia
  著者:: Faulkner, Lawrence, 等
  出版事項: (2017)
• Durable Survival Outcomes in Primary and Secondary Central Nervous System Lymphoma After High-dose Chemotherapy and Autologous Stem Cell Transplantation Using a Thiotepa, Busulfan, and Cyclophosphamide Conditioning Regimen
  著者:: Young, Patricia A., 等
  出版事項: (2020)
• Phase II Trial of High-Dose Rituximab with High-dose Cytarabine Mobilization Therapy and High-Dose Thiotepa, Busulfan, and Cyclophosphamide (R-TBC) Autologous Stem Cell Transplant in Patients with CNS Involvement by Non-Hodgkin Lymphoma
  著者:: Chen, Yi-Bin, 等
  出版事項: (2014)
• Prolonged third complete remission after busulfan, thiotepa, and autologous stem cell transplant in a primary central nervous system lymphoma patient
  著者:: Camus, Vincent, 等
  出版事項: (2018)